According to GlobalData’s company profile on Acorda Therapeutics, Human telomerase RT biomarker was a key innovation area identified from patents. Acorda Therapeutics's grant share as of July 2024 was ...
According to a study that was published on October 7th, 2024, in the Journal of the American Chemical Society, researchers from Yokohama National University aim to lessen the environmental impact of ...
Discover how Xenon Pharmaceuticals' new patent for sodium channel-modulating compounds could revolutionize treatments for epilepsy and other neurological disorders.